Meet Zinnia (Naoshin) Noor, Scientific Application Manager (International Distribution Sales)
Read out our latest employee profile about Dr Zinnia Noor, our scientific application manager….
Go To Page
Profile
Profile Who we are At PromoCell, we help scientists do better research with a world-class portfolio of human primary, stem and blood cells as well as optimized cell culture media. With over 30 years of expertise, we are recognized globally for supplying scientists with the tools and support they need to do groundbreaking research….
Go To Page
PromoCell announces services for large-scale industrial lots of Mesenchymal Stem Cells
– New services for large-scale industrial lots allows customers to have high volumes of standardized MSC populations derived from bone marrow and adipose tissue
– Guaranteed MSC functionality and phenotype in accordance to ISCT* guidelines
– Optimized media with complete supplementation and expert technical support…
Go To Page
HLA class II typed cells to accelerate effective research on immunotherapies
We support effective research on immunotherapies by expanding the range of HLA-types provided for all Human Primary Cells and Blood & Stem Cells. In addition to the MHC class I genes HLA-A, -B, and -C, we now also offer 4-digit resolution for MHC class II genes HLA-DPA1/DPB1, -DQA1/DQB1, and -DRB1/DRB345.
The Human Leukocyte Antigen (HLA) system plays a fundamental role in the determination of histocompatibility between different individuals and regulation of the human immunity….
Go To Page
Custom Solutions
Our custom services: Contact us via online form via email at custom.solutions@promocell.com or call +49 6221 649 34 0 to let us know your requirements. We’ll be more than happy to discuss the possibilities with you. Why PromoCell? Our support team, consisting of highly qualified PhD scientists, is devoted to providing you with the highest level of personalized service available in the market….
Go To Page
Career
At PromoCell, we have dedicated professionals to help scientists do better research with a world-class portfolio of human primary, stem and blood cells as well as optimized cell culture media. Looking to become one of them in a challenging and rewarding work environment? Join our team of dedicated professionals – there’s a world of scientific discovery waiting for you….
Go To Page
The importance of MSC characterization
Characterization of mesenchymal stem cells (MSCs) is vital for their successful application in regenerative medicine. These multipotent cells can differentiate into several cell types, making them a promising therapeutic option for various diseases. In our blog post, we discuss the importance of MSC characterization in ensuring standardized and reproducible cell isolation,…
Go To Page
Histocompatibility: Piecing together the immunotherapy puzzle
What do puzzles and immunity have in common? The human leukocyte antigen (HLA) system of cell-surface proteins help to regulate the immune system. Yet particular antigens can make a crucial difference. Patients with certain HLA types are more likely to have autoimmune diseases, contract infectious disease or develop cancer. Now, through better understanding of HLA function,…
Go To Page
Privacy Policy
Proper protection of your personal data is a serious matter for PromoCell GmbH and we conform strictly to all data protection laws and regulations. The following declaration provides an overview of how we ensure this protection, as well as which types of data are collected and to what purpose. Scope of application This privacy statement informs users of the types,…
Go To Page
Stem cell therapy scientist: Finding inspiration outside his comfort zone
Crossing the border between medical and biomechanical research fuels the research of stem cell specialist Dr. Diego Correa. We talked to the Colombian-born stem cell scientist, a former clinician with training in mechanical engineering, about his studies with mesenchymal stem cells and their potential clinical applications in cell-based therapy. Soon Correa is going to publish what he believes will be his most important contribution to this field….
Go To Page
Malignant mesothelioma: Paving the way for new therapies
From bench to bedside and back: This is the direction of malignant mesothelioma research. Yet to understand the biology of this particular type of cancer, more basic insights are still needed. And translating that knowledge into new therapies is extremely important, as only limited therapeutic options exist so far.
Molecular needles that cross the lung epithelium: That’s how asbestos – often in form of dust – enters lung tissue (Carbone et al.,…
Go To Page
Branching out: In vitro angiogenesis advancements
In this interview with RegMedNet, our expert, Iris Bischoff-Kont, discusses the latest advancements in angiogenesis research and their potential applications in regenerative medicine. Dr Bischoff-Kont also explores the challenges faced in translating angiogenesis research findings into clinical therapies and the importance of understanding the crosstalk between angiogenesis and other processes like inflammation….
Go To Page